The incidence of melanoma is increasing dramatically in both females and males, but male melanoma patients have been found to have shorter survival than female melanoma patients.

The aim of this retrospective study, performed on a population of 1023 patients with cutaneous melanoma, was to evaluate the difference in survival between male and female melanoma patients, as well as the relationship of this survival difference with the pathological features of the neoplasm.

The results demonstrate that female melanoma patients do have an advantage over their male counterparts in terms of both disease-free survival and overall survival.